Randox Showcases Latest Developments for Diagnostics Market at Medlab Middle East 2023

Randox Laboratories (Crumlin, UK) is showcasing its latest developments for the diagnostics market at Medlab Middle East 2023 taking place live, in-person from 6-9 February 2023, in Dubai.

At the 22nd edition of Medlab Middle East Congress, Randox is highlighting its RX series of clinical chemistry analyzers for high quality semi-automated and fully automated testing, including RX daytona+, RX Monaco, RX imola, RX Modena, and RX misano. The RX series combines robust hardware and intuitive software with the world leading RX series test menu, including routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing. Renowned for quality and reliability, the RX series has one of the most extensive dedicated clinical chemistry test menus on the market guaranteeing real cost savings through consolidation of routine and specialized tests onto a single platform. This extensive dedicated test menu of high quality reagents guarantees excellence in patient care ensuring unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results. With placements in over 120 countries worldwide, the RX series continues to revolutionize a variety of laboratory types including clinical laboratories and hospital laboratories.

At this year’s Medlab Middle East, Randox is also showcasing the Vivalytic platform, a universal, fully automated all in one solution for molecular diagnostics, the VeraSTAT portable point of care reader based on cathodic electro chemiluminescence technology, and the Discovery molecular & immunoassay diagnostic analyzer. Also on display at the show is the fully automated Evidence MultiSTAT immunoanalyser that enables on-site simultaneous detection of up to 44 analytes from a single sample of oral fluid, urine or blood.

In addition, Randox is presenting its extensive range of third party diagnostic reagents which produce accurate and precise results, alongside Acusera true third party quality controls that offer complete test menu consolidation for laboratory Internal Quality Control. Alongside, Randox is demonstrating Acusera 24.7, an Interlaboratory data management and peer group reporting package complementing the Acusera range of true third-party controls. Designed to help laboratories efficiently and effectively manage their daily QC activities, Acusera 24.7 offers several benefits to laboratories.

Related Links:
Randox Laboratories

Visit expo >

New

Platinum Member

Flu SARS-CoV-2 Combo Test

OSOM® Flu SARS-CoV-2 Combo Test

Magnetic Bead Separation Modules
MAG and HEATMAG

Complement 3 (C3) Test

GPP-100 C3 Kit

Gold Member

Liquid Ready-To-Use Lp(a) Reagent

Lipoprotein (a) Reagent